Skip to main content
logo
Silence Therapeutics plc (SLNCF)
OTCMKTS · Delayed Price · Currency is USD
1.600
0.00 (0.00%)
Jul 23, 2025, 8:00 PM EDT

Silence Therapeutics Revenue

Silence Therapeutics had revenue of $142.00K in the quarter ending March 31, 2025, a decrease of -99.10%. This brings the company's revenue in the last twelve months to $27.70M, down -16.00% year-over-year. In the year 2024, Silence Therapeutics had annual revenue of $43.26M with 36.71% growth.

Revenue (ttm)
27.70M
Revenue Growth
-16.00%
P/S Ratio
10.81
Revenue / Employee
238.80K
Employees
116
Market Cap
299.44M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202443.26M11.62M36.71%
Dec 31, 202331.64M9.99M46.12%
Dec 31, 202221.66M4.84M28.82%
Dec 31, 202116.81M9.33M124.73%
Dec 31, 20207.48M7.16M2,214.81%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Endo, Inc.1.73B
Veradigm588.02M
Tian'an Technology Group1.78M
Elite Pharmaceuticals84.04M
Glass House Brands215.62M
Northwest Biotherapeutics1.47M
American Oncology Network1.76B
BioStem Technologies332.45M
Revenue Rankings

Silence Therapeutics News

More News